PET/MRI in PAH Patients
NCT03688698 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37
Last updated 2018-09-28
Summary
Aim of the study is to compare novel parameters of right ventricle (RV) function from right heart catheterization (RHC) and magnetic resonance imaging (MRI) with PET-derived RV FDG uptake.
Conditions
Interventions
- RADIATION
-
PET/MRI
PET/MRI scans
Sponsors & Collaborators
-
Medical University of Bialystok
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-05-01
- Primary Completion
- 2017-06-01
- Completion
- 2018-01-01
More Related Trials
-
Cardiac Magnetic Resonance Imaging and Pulmonary Perfusion
NCT01100008 ·Status: COMPLETED ·Phase: NA
-
Novel Quantitative Magnetic Resonance Imaging (MRI) Measures in the Assessment and Follow-up of Patients With Pulmonary Hypertension (PH)
NCT04088279 ·Status: UNKNOWN ·Phase: NA
-
Study of Cardiac MRI in the Follow up Assessment of Patients With PAH (EVITA)
NCT02845518 ·Status: RECRUITING ·Phase: NA
-
4D-flow Cardiac MRI to Assess Pulmonary Arterial Pressure in Pulmonary Hypertension
NCT05103189 ·Status: COMPLETED ·Phase: NA
-
129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)
NCT06104228 ·Status: RECRUITING ·Phase: PHASE2
-
Magnetic Resonance Imaging in the Diagnosis of Pulmonary Hypertension
NCT00575692 ·Status: COMPLETED
-
The Prognostic Role of the Right Ventricle in Patients With Heart Failure or Congenital Heart Disease
NCT03969394 ·Status: UNKNOWN ·Phase: NA
-
Non-contrast Enhanced Cardiac Magnetic Resonance Imaging in the Diagnosis and Classification of Pulmonary Hypertension
NCT01725763 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Ventricular Reversed Remodeling After LTX in PAH Patients
NCT02391441 ·Status: COMPLETED
-
Clinical Research on 68Ga-FAPI PET/CMR in Cardiovascular Diseases
NCT07063043 ·Status: RECRUITING
-
Right Ventricular and Pulmonary Artery Evaluation by CMR
NCT03377673 ·Status: UNKNOWN
-
Tissue and Metabolic Characterization of Arrhythmogenic Cardiomyopathies by Hybrid PET-MRI Imaging, Impact of the Observed Profiles on the Phenotype and on the Evolution of Cardiomyopathy
NCT05450783 ·Status: RECRUITING
-
Cardiac MRI in Pulmonary Hypertension
NCT02485977 ·Status: COMPLETED
-
Validation of PET-MRI for Cardiovascular Disease
NCT02988531 ·Status: COMPLETED ·Phase: NA
-
Diagnosis of Pulmonary Hypertension Using Cardiac Magnetic Resonance Images
NCT02790918 ·Status: COMPLETED
-
Respiratory Motion Correction of Cardiac Combined Positron Emission Tomography and Magnetic Resonance Imaging (PET/MRI)
NCT03200132 ·Status: COMPLETED
-
Technical Development of Cardiovascular Magnetic Resonance Imaging
NCT04927429 ·Status: RECRUITING
-
129Xe MRI Cardiopulmonary
NCT06038630 ·Status: RECRUITING ·Phase: PHASE2
-
18F-GP1 PET-CT to Detect Bioprosthetic Aortic Valve Thrombosis
NCT04073875 ·Status: COMPLETED
-
F-18 Rhodamine 6G PET Imaging for Myocardial Blood Flow
NCT04528758 ·Status: SUSPENDED ·Phase: EARLY_PHASE1
-
Right Heart Dysfunction and Pulmonary Hypertension Evaluation in Airway Disease Using Cardiac Magnetic Resonance
NCT02865577 ·Status: COMPLETED
-
Technical Development of Cardiovascular Magnetic Resonance Imaging
NCT00064896 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study of Evaluating Myocardial Viability in Ischemic Heart Disease with Integrated 18F-FDG PET/MR
NCT06712862 ·Status: RECRUITING
-
Assessment of Right Ventricular Function by Cardiac MRI in Patients With Pulmonary Arterial Hypertension (IRMA)
NCT05624242 ·Status: COMPLETED
-
Cardiac Fibroblast Activation Detected by 68Ga-FAPI PET/MR
NCT04723953 ·Status: COMPLETED ·Phase: NA